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derwent implantation of 33 stenta in 8 IFV (5 occluded, 3 obstructed) and
4 WC (2 occluded, 2 obstructed). While wires were passed across the cb
structed vessels for atent placement, occluded vessels required puncture
through the thrombosad sites using a stiff wire or transseptal needle. A
catheter placed from the internal jugular vein to the site of obstruction was
used as a guide for the puncture. Once crossed, the obstructed site was
serially dilated prior to stent implantation. Results: The mean diameter of 5
obstructed vessels was 2.3 + 3.2 mm. Following stent placement of all 12
vessels (occluded and obstructed), the mean diameter was 8.9 + 3.0 mm
(p < 0.05). 8/10 pts had long segments of occlusiorVobstruction requiring
2-7 overlapping stents. Further diagnostic catheterizations were petiormad
in 5 patients via the stented vessels at mean follow-up of 9.8 mo. All ves-
selslstents remained patent with mean diameter of6.4 + 2.0 mm. Inaddition,
the stentad vessel was utilized for endomyocardial biopsies in one pt and for
vascular access during subsequent cardiac surgery in another. Conclusion:
Oooludedlobstructed IFV and IVC maybe reconstructed using stents to re-
established venous access to the heart for future cardiac catheterizations
ardor surgeries.
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729-2 TranshapsticThsrspauticCardiacCathatsrizstion:A
NovalApproachfor tha Intarvantionalist
D. Shim, T.R. Lloyd’, R.H. Beekman, Ill. Chi/dren’s Hospital Medical
Centec Cincinnati, Ohio, USA, 1C.S. Motf Children’s Hospital, Ann Arboc
Michigan, USA
To evaluate efficacy and safety of transhepatic (TH) venous access for
interventional cardiac catheterization (CC), a retrospective review of 11 pts
with a median age of 19 mos (range: 1 dy-41 yra) and weight of 9.2 kg (3.1–
73.6 kg) was performed. Indications for TH access were bilateral obstructed
femoral veins (n=7), interrupted inferiorvenacava(n = 1),obstrucfedfemoral
veina and superior vena cava (n = 2), and presumptive improved route for
intervention via TH access (n = 3). Interventions performed via the TH route
included pulmonary valvuloplssfy (n = 3), pulmonary angioplasty (n = 2),
and 1 each of atrfal septal defect device closure, transseptal puncture with
mitral vahruloplasty,superfor vena csva stent placement, bilateral pulmonaty
angioplasty and stent placement, pulmonary stent redilation, and cardiac
biopsy. TH access was achieved in a median time of 9.0 min (3-12 rein) with
sheath sizes of 4-12 Fr.TH CC allowed successful interventions in 10/11pts
(91%). TH interventional CC was not successful in a newborn with critical
pulmonic stenosis and diminutive right ventricle; the advent of a precurved
TH sheath has subsequently facilitated catheter passsge across the tricuspid
valve. There were no changes in pre and lmst-TH CC hemoglobin levels
(mean + SD: 12.9+ 2.0 vs 12.1 + 2.2 gm/dL; p= NS) or alaninetrensferase
(36.9 + 27.9 vs 45.0 + 18.5 IU/L; p = NS). No complications of bleeding,
suboapsular Iiverhematoma, orpneumothorsx were notedon Iiverultrasound
or chest radiograph.
Conclusion: TH CC is safe and effective as a route for interventional
procedures for patients with limited venous access.
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n7293 TranacsthatarOccluaionof PatantDuctusArterioausandAorto-PulmonaryCollataralaUsing
tha Gianturco-GrifksVaacularOcclusionDavice
R.G. Grifka, F.F.Ing, W.S. McMahon, M.R. Nihill, M.P.O’Leughlin,
W.R. Morrow, J.W. Wiggins, C.E. Mullins. TexasChildren’s Hospital,
Houston, TX, USA
Devices have been developed for transcstheter vascular occlusion. The
present devices have limitations including inability to adjust device posi-
tion, embolization, and residual leaks. Two common congenital heart de-
fects which are occluded with devices are patent ductus arteriosus (PDA)
and aortopulmonary collateral vessels (Ao-PA). We report results using the
Gianturco-Grifka Vascular occlusion device (GGVOD) to occlude PDA and
Ao-PA. The GGVOD consists of a nylon sack attached to an end-hole
catheter; a filler wire is inserted through the catheter into sack.
In 17pts, 18vessels(15-PDA, 3-Ao-PA)were occluded usingthe GGVOD.
Age ranged from 2 mo to 61 yr (median 2.5 yr), weight ranged from 4.5
to 85 kg (median 9.4 kg). Vessel diameter ranged from 2.6 to 6.1 mm
(mean 4.1 mm). The QP:Qs = 2.1 + 0.44. The GGVOD was implanted in a
length of vessel ? the device diameter. The GGVOD size was 0.7–1.8 mm
larger than the vessel diameter. In 14 of 18 implants, prior to releasing the
GGVOD, the device was repositioned toanoptimal position. Inall 16vessels,
the GGVOD was implanted without problems, resulting in 100% complete
occlusion. There were no device embolizations.
All pta had follow-up clinic evaluations 1 to 16 mo post-GGVOD implant.
There have been no late device embolizations and eve~ vessel remains
completely occluded.
Conclusion: The GGVOD is a safe and effective transcstheter occlusion
device for tubular PDA and Ao-PA collateral vessels. The GGVOD maybe
useful to occlude additional vascular defects.
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PatentDuctuaArtariosua
C.J. Daniels, SC. Cassidy, D.W. Teske, J.J. Wheller, H.D. Allen. Columbus
Children’s Hospital and The Ohio State University, Columbus, Ohio, USA
Cardiac catheterization guided coil occlusion is an accepted method tocloae
patent ductus arteflosus (PDA). Procedural success is mnfirmed by an-
giography and post-catheterization Doppler-eohocardiography demonstrat-
ing obliteration of PDA flow into the pulmonary artery. During evaluation
of prospectively collected data on 23 patients who had PDA coil occlusion
using Gianturco spring coils from May 1995 to May 1996, we found some
that had reopened after carefully documented successful closure. This study
was performd to determine the number that reopened and any independent
variables that may be predictive of reopening. The study group included 16
patients who have completed a 6 month follow-up period. All had Doppler-
eohocardiogramswithin 24 hours and at4-6 months post-PDAcoil occlusion.
The patients that reopened after early successful closure were compared to
all other patients by stepwise regression analysis using independent vari-
ables including aga, sex, patient weight, catheterization date (early vs late
experience), hepsrin use, PDA minimal and maximal diameter, and PDA
length and by unpaired t-testing comparing PDA minimal diameter, maximal
diameter, and length. PDA early closure was successful in 16/18 patients
(69%). PDA reopening after successful closure was diagnosed at late follow-
up in 5 patients. Late coil migration was documented in 1 patient. Stepwise
regression analysis demonstrated that only PDA length significantly pre-
dicted PDA reopening (p < 0.01). Likewise, unpaired t-testing ahowed the
PDA length to be the only significant variable predictive of reopening. PDA
mean length was 2.9 (range 1.0 to 6.0) and 7.5 (range 3.7 to 12.0) mm, re-
spectively, for the reopened and all other patients (p < 0.01). For PDA length
<3.5 mm, positive and negative predictive values for reopening were 100%
and 93%, respectively. Short PDA length was the only independent vari-
able that significantly predicted reopening, suggesting that in such anatomy,
alternatives to coil occlusion should be considered.
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Comparisonof ths Rasuttsusingths Rashkind
UmbrellaandDiffarentTypssof OcclusionCoilsin
1,306procsdurssfroma EuropeanRsgistry
I.C. Huggon, S.A. Qureshi, for the European Registty. Guy’s Hospital,
London, UK
Patiicipating cardiologists submitted date to a registry recording attempted
transcatheter occlusion of the arterial duct. Details given included the de-
vices used, failures of implantation, embolisation of the device and time
course to echocardiographic complete occlusion. Results are available for
1,308 attempted procedures in 1,231 patienta. Of 992 Rashkind umbrella
procedures, 77 (7.77.) were fOr residual ducts fOllOWiflgligatiOnor preViOUS
transcstheter occlusion. Forty-four (14%) of 314 coil procedures were for
residual ducts. Jackson (Cook) or Duct Occlud controlled-release coils were
successfullydeployed in 275 procedures and other coil types oroombinations
in 29. The mean number of coils implanted per duct was 1.47. Controlled-
release coils embolised in 6 procedures (2.9%), standard roils in 4 (13.7%)
and Rashkind umbrellas in 23 (z.s~o). Kaplan-Meier curves for freadom from
residual flow after implantation of coils and umbrellas are shown. The pro-
portion with complete occlusion at 20 months was 64% with the umbrella
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